Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β. Hegen H, Auer M, Deisenhammer F Expert Opin Drug Metab Toxicol. 2015 Sep 30:1-17. PMID: 26419922. Abstract CommentRecommendBookmarkWatch